Details of the Drug Combination

General Information of Drug Combination (ID: DCWOIP6)

Drug Combination Name

Regadenoson Gadopentetate dimeglumine

Indication

Disease Entry	Status	REF
Heart Transplant	Phase 4	[1]

Component Drugs

Regadenoson DM76VHG

Gadopentetate dimeglumine DMJ62BV

Small molecular drug

2D MOL

3D MOL

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)

Indication(s) of Regadenoson

Disease Entry	ICD 11	Status	REF
Radionuclide imaging	N.A.	Approved	[2]

Regadenoson Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Adenosine A2a receptor (ADORA2A)	TTM2AOE	AA2AR_HUMAN	Modulator	[3]
------------------------------------------------------------------------------------

Indication(s) of Gadopentetate dimeglumine

Disease Entry	ICD 11	Status	REF
Carcinoma	2A00-2F9Z	Approved	[3]

References

1	ClinicalTrials.gov (NCT02597543) Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5596).
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015